ATE389653T1 - 4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen - Google Patents

4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen

Info

Publication number
ATE389653T1
ATE389653T1 AT04734885T AT04734885T ATE389653T1 AT E389653 T1 ATE389653 T1 AT E389653T1 AT 04734885 T AT04734885 T AT 04734885T AT 04734885 T AT04734885 T AT 04734885T AT E389653 T1 ATE389653 T1 AT E389653T1
Authority
AT
Austria
Prior art keywords
pyrazolo
pyrimidine
substituted derivatives
nhch2c6h5
nhc4h9
Prior art date
Application number
AT04734885T
Other languages
English (en)
Inventor
Francesco Bondavalli
Maurizio Botta
Olga Bruno
Fabrizio Manetti
Silvia Schenone
Fabio Carraro
Original Assignee
Univ Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT000264A external-priority patent/ITRM20030264A1/it
Priority claimed from IT000263A external-priority patent/ITRM20030263A1/it
Application filed by Univ Siena filed Critical Univ Siena
Application granted granted Critical
Publication of ATE389653T1 publication Critical patent/ATE389653T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04734885T 2003-05-28 2004-05-26 4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen ATE389653T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000264A ITRM20030264A1 (it) 2003-05-28 2003-05-28 Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-
IT000263A ITRM20030263A1 (it) 2003-05-28 2003-05-28 Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-

Publications (1)

Publication Number Publication Date
ATE389653T1 true ATE389653T1 (de) 2008-04-15

Family

ID=33492308

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04734885T ATE389653T1 (de) 2003-05-28 2004-05-26 4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen

Country Status (8)

Country Link
US (1) US7589086B2 (de)
EP (1) EP1638966B1 (de)
JP (1) JP4642766B2 (de)
AT (1) ATE389653T1 (de)
CA (1) CA2527496C (de)
DE (1) DE602004012559T2 (de)
ES (1) ES2304252T3 (de)
WO (2) WO2004106340A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1746099A1 (de) * 2004-12-23 2007-01-24 DeveloGen Aktiengesellschaft Mnk1 or Mnk2 Inhibitoren
JP5274842B2 (ja) * 2004-12-28 2013-08-28 エグゼリクシス, インコーポレイテッド 免疫疾患、炎症疾患および増殖疾患の処置のためのセリン−スレオニンキナーゼモジュレーター(p70S6K、Akt−1およびAkt−2)としての[1H−ピペラゾ[3,4−d]ピリミジン−4−イル]−ピペラジンまたは[1H−ピペラゾ[3,4−d]ピリミジン−4−イル]−ピペラジン化合物
US7558755B2 (en) * 2005-07-13 2009-07-07 Mott Antony R Methods and systems for valuing investments, budgets and decisions
GB0524436D0 (en) * 2005-11-30 2006-01-11 Novartis Ag Organic compounds
CN101466716A (zh) 2006-04-07 2009-06-24 德维洛根股份公司 用于药物组合物的具有mnkl/mnk2抑制活性的噻吩并嘧啶
EP1889847A1 (de) 2006-07-10 2008-02-20 DeveloGen Aktiengesellschaft Pyrrolopyrimidine zur pharmazeutischen Anwendung
WO2009034547A2 (en) * 2007-09-14 2009-03-19 Università Degli Studi Di Siena New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof
AU2009286734A1 (en) 2008-08-26 2010-03-04 Boehringer Ingelheim International Gmbh Thienopyrimidines for pharmaceutical compositions
UY33241A (es) 2010-02-26 2011-09-30 Boehringer Ingelheim Int ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
BR112012021453A2 (pt) 2010-02-26 2017-02-21 Boehringer Ingelheim Int tienopirimidina, sua composição farmacêutica e seu uso
PH12012501693A1 (en) 2010-02-26 2012-11-05 Boehringer Ingelheim Int 4 - [cycloalkyloxy (hetero) arylamino] thieno [2,3 - d] pyrimidines having mnkl/mnk2 inhibiting activity for pharmaceutical compositions
US9290499B2 (en) 2010-05-19 2016-03-22 The University Of North Carolina At Chapel Hill Pyrazolopyrimidine compounds for the treatment of cancer
EP2632920A1 (de) 2010-10-27 2013-09-04 Dynamix Pharmaceuticals Ltd. Sulfonamide zur modulation von pkm2
WO2013052417A1 (en) 2011-10-03 2013-04-11 The University Of North Carolina At Chapel Hill Pyrrolopyrimidine compounds for the treatment of cancer
RU2014145121A (ru) 2012-05-22 2016-07-10 Зэ Юниверсити Оф Норд Каролина Эт Чапел Хилл Пиримидиновые соединения для лечения злокачественной опухоли
CN103570723B (zh) 2012-07-27 2016-07-13 广西梧州制药(集团)股份有限公司 吡唑并嘧啶衍生物及其制备方法和在药物制备中的用途
EP2909211A4 (de) 2012-10-17 2016-06-22 Univ North Carolina Pyrazolopyrimidinverbindungen zur krebsbehandlung
EP2925752A4 (de) 2012-11-27 2016-06-01 Univ North Carolina Pyrimidinverbindungen zur krebsbehandlung
WO2015157122A1 (en) 2014-04-11 2015-10-15 The University Of North Carolina At Chapel Hill Mertk-specific pyrazolopyrimidine compounds
US10709708B2 (en) 2016-03-17 2020-07-14 The University Of North Carolina At Chapel Hill Method of treating cancer with a combination of MER tyrosine kinase inhibitor and an epidermal growth factor receptor (EGFR) inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208293A (ja) * 1982-05-20 1983-12-03 Lion Corp 1H−ピラゾロ〔3,4−d〕ピリミジン誘導体及び該化合物を含有する抗腫瘍剤
AU711592B2 (en) * 1995-04-03 1999-10-14 Novartis Ag Pyrazole derivatives and processes for the preparation thereof
WO2003029209A2 (en) * 2001-10-02 2003-04-10 Smithkline Beecham Corporation Chemical compounds

Also Published As

Publication number Publication date
US7589086B2 (en) 2009-09-15
DE602004012559D1 (de) 2008-04-30
CA2527496A1 (en) 2004-12-09
ES2304252T3 (es) 2008-10-01
CA2527496C (en) 2012-08-14
WO2004106339A2 (en) 2004-12-09
US20070010510A1 (en) 2007-01-11
WO2004106340A2 (en) 2004-12-09
EP1638966A2 (de) 2006-03-29
WO2004106339A3 (en) 2005-02-17
EP1638966B1 (de) 2008-03-19
WO2004106340A3 (en) 2005-02-17
JP2007500206A (ja) 2007-01-11
JP4642766B2 (ja) 2011-03-02
DE602004012559T2 (de) 2009-04-30

Similar Documents

Publication Publication Date Title
ATE389653T1 (de) 4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen
PL359563A1 (pl) Związki pirolo [2,3-d] pirymidynowe jako środki immunosupresyjne
ATE362474T1 (de) Pyrazolo(1,5-a)pyrimidine als hemmstoffe cyclin- abhängiger kinasen
AU2002357773A1 (en) 1,6 naphthyridines useful as inhibitors of syk kinase
DK1278735T3 (da) 2,4-di(hetero-)arylamino(-oxy)-5-substituerede pyrimidiner som antineoplastiske midler
WO2004031401A3 (en) Novel tyrosine kinases inhibitors
WO2007023111A3 (en) P38 map kinase inhibitors and methods for using the same
TW200608977A (en) Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
MXPA05008584A (es) Compuestos heterociclicos utiles como activadores de nurr-1.
WO2004063151A3 (en) Novel tyrosine kinase inhibitors
CY1110319T1 (el) Ενωσεις 7-φενυλ πυραζολοπυριδινης
WO2002085906A3 (en) Phthalazinones derivatives useful as pde4/7 inhibitors
MXPA04006041A (es) Antivirales de piridoquinoxalina.
CA2452036A1 (en) 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
EA200301101A1 (ru) Производные пиперазина и их применение в качестве ингибиторов pde4
DK1742950T3 (da) Pyrazolo-[4,3-D]-pyrimidiner
DE69910574D1 (de) Pyrazolo[1,5-a]triazine als crf antagonisten
TW200635928A (en) 7-Amino-6-heteroaryl-1,2,4-triazolo[1,5-a]pyrimidine and the use thereof for controlling harmful fungi
DK1307463T3 (da) Pyrrolo[2,1-b][1,3]benzothiazepiner og deres anvendelse til fremstillingen af medikamenter med antipsykotisk aktivitet
UY26791A1 (es) Compuestos de pirrol (2,3-d) pirimidina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1638966

Country of ref document: EP